NCT04695327 2026-03-06
TUNIMO
TILT Biotherapeutics Ltd.
Phase 1 Completed
Clinical Trials
12 trialsNCT03916510 2025-02-06
CEDAR
University of Oxford
Phase 1 Completed
NCT02555397 2024-10-10
Phase 1 Trial of Interleukin 12 Gene Therapy for Locally Recurrent Prostate Cancer
Henry Ford Health System
Phase 1 Completed
NCT04374240 2021-11-03
AdUP
University of Birmingham
Phase 1 Completed
NCT01535885 2021-10-25
ACE
Medical College of Wisconsin
Phase 1 Completed
NCT00031083 2020-11-17
Dose Escalation Study to Determine the Safety of IFN-Beta Gene Transfer in the Treatment of Grade III & Grade IV Gliomas
Biogen
Phase 1 Completed
NCT03384316 2020-09-09
Multi-Targeted Recombinant Ad5 (CEA/MUC1/Brachyury) Based Immunotherapy Vaccine Regimen in People With Advanced Cancer
National Institutes of Health Clinical Center (CC)
Phase 1 Completed
NCT02894944 2019-09-12
Theragene
Seoul National University Hospital
Phase 1 Completed
NCT00372320 2018-09-11
Effect of AdhAQP1 on Salivary Flow in Patients Treated With Radiation for Head and Neck Cancer
National Institutes of Health Clinical Center (CC)
Phase 1 Completed
NCT02654938 2017-09-20
Safety and Tolerability Clinical Trial of Different Doses of the Immunotherapeutic Drug Mobilan (M-VM3) and Placebo in Patients With Prostate Cancer
Panacela Labs LLC
Phase 1 Completed
NCT01864759 2017-08-29
Phase I Endovenous Administration of Oncolytic Adenovirus ICOVIR-5 in Patients With Advanced or Metastatic Melanoma
Institut Català d'Oncologia
Phase 1 Completed
NCT01070797 2014-09-04
VIRAGE
Baylor College of Medicine
Phase 1 Completed